No Data
No Data
Beam Therapeutics Analyst Ratings
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
Cathie Wood-Led Ark Invest Sells $8M In Tesla Shares Despite Bullish Autonomy Forecast
Where CareDx Stands With Analysts
CareDx Analyst Ratings
The Latest Analyst Ratings For Ionis Pharmaceuticals
Forever 365 :![apple 🍎](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f34e.png)
![man-lifting-weights 🏋️♂️](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f3cb-1f3fb-200d-2642-fe0f.png)
![slot_machine 🎰](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f3b0.png)
![i_love_you_hand_sign 🤟](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f91f.png)
![joy 😂](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f602.png)
OceansWave : A lot of market moving events for this week.. so have you started to sell puts for NVDA? I am loading on the stock hahahah
Cow Moo-neyOP OceansWave: Haven’t haha. Waiting for lower price to sell put and to load up shares![grimacing 😬](https://static.moomoo.com/nnq/emoji/static/image/img-apple-64/1f62c.png)
OceansWave : Haha